Harvey D White Selected Research

Valsartan (Vals)

4/2014	Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).
6/2010	Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.
9/2009	Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
6/2009	Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).
12/2008	Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
4/2008	High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
3/2007	Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
9/2006	Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
11/2005	Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
10/2005	Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harvey D White Research Topics

Disease

189	Myocardial Infarction 11/2023 - 06/2002
171	Acute Coronary Syndrome 11/2023 - 01/2002
130	Hemorrhage 11/2023 - 02/2002
61	Ischemia 01/2023 - 09/2002
58	Stroke (Strokes) 12/2021 - 12/2002
49	ST Elevation Myocardial Infarction 01/2022 - 09/2002
47	Coronary Disease (Coronary Heart Disease) 01/2023 - 03/2002
44	Thrombosis (Thrombus) 10/2023 - 06/2002
33	Unstable Angina 01/2023 - 07/2002
31	Heart Failure 01/2023 - 01/2002
23	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 01/2002
21	Infarction (Infarctions) 03/2020 - 02/2002
16	Atrial Fibrillation 01/2022 - 12/2002
15	Ischemic Stroke 04/2024 - 12/2011
15	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2004
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 03/2002
10	Left Ventricular Dysfunction 01/2018 - 08/2003
9	Atherosclerosis 03/2023 - 02/2009
8	Diabetes Mellitus 04/2024 - 02/2009
8	Stable Angina 12/2023 - 07/2008
8	Hypertension (High Blood Pressure) 09/2022 - 01/2002
8	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2002
8	Inflammation (Inflammations) 12/2021 - 11/2004
7	Non-ST Elevated Myocardial Infarction 01/2018 - 09/2002
6	Chronic Renal Insufficiency 04/2024 - 08/2009
6	Obesity 07/2019 - 08/2008
6	Pathologic Constriction (Stenosis) 06/2014 - 01/2003
5	Renal Insufficiency (Renal Failure) 01/2022 - 01/2007
5	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2017
5	Peripheral Arterial Disease 09/2021 - 10/2014
5	Transient Ischemic Attack 11/2019 - 02/2010
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018 - 02/2004
5	Vascular Diseases (Vascular Disease) 10/2018 - 06/2006
5	Neoplasms (Cancer) 01/2018 - 01/2016
5	Bundle-Branch Block (Fascicular Block) 06/2014 - 01/2000
5	Cardiogenic Shock 06/2014 - 10/2003
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2018
4	Cardiomyopathies (Cardiomyopathy) 01/2020 - 04/2015
4	Thrombocytopenia (Thrombopenia) 01/2018 - 02/2011

Drug/Important Bio-Agent (IBA)

56	Clopidogrel (Plavix)FDA Link 01/2022 - 11/2006
51	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 06/2002
35	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2023 - 03/2002
35	Glycoproteins (Glycoprotein)IBA 01/2018 - 06/2002
34	bivalirudin (Angiomax)FDA Link 03/2020 - 02/2002
32	cangrelorIBA 03/2022 - 12/2009
32	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 06/2002
32	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 09/2002
31	alirocumabIBA 04/2024 - 11/2018
27	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2004
24	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2009
21	vorapaxarIBA 12/2018 - 03/2011
20	darapladibIBA 01/2022 - 04/2011
20	Thrombin Receptors (Thrombin Receptor)IBA 01/2020 - 01/2012
19	omega-Chloroacetophenone (Mace)IBA 01/2024 - 02/2011
18	TroponinIBA 01/2022 - 07/2008
18	Streptokinase FDA Link 09/2019 - 06/2002
17	CreatinineIBA 01/2022 - 12/2002
15	LDL CholesterolIBA 03/2023 - 06/2015
15	LipidsIBA 01/2022 - 03/2002
14	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 04/2003
14	Pravastatin (Pravachol)FDA LinkGeneric 01/2022 - 10/2002
13	C-Reactive ProteinIBA 01/2024 - 11/2003
13	AntithrombinsIBA 01/2012 - 06/2002
12	Valsartan (Vals)FDA Link 04/2014 - 08/2003
11	oxidized low density lipoproteinIBA 10/2022 - 12/2011
9	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2024 - 10/2011
9	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 11/2004
9	Lipoprotein(a)IBA 10/2023 - 12/2013
8	Troponin T (Troponin T1)IBA 01/2024 - 03/2003
8	Hemoglobins (Hemoglobin)IBA 11/2023 - 03/2008
8	Platelet Membrane Glycoprotein IIbIBA 05/2015 - 12/2002
7	Lipoproteins (Lipoprotein)IBA 09/2022 - 04/2011
7	CholesterolIBA 12/2020 - 10/2002
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 01/2007
7	Warfarin (Coumadin)FDA LinkGeneric 03/2014 - 02/2007
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2023 - 01/2016
6	Proprotein Convertase 9IBA 01/2022 - 11/2018
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2011
6	Tirofiban (Aggrastat)FDA Link 01/2016 - 08/2002
5	Cystatin CIBA 01/2024 - 01/2017
5	Interleukin-6 (Interleukin 6)IBA 01/2024 - 10/2017
5	TicagrelorIBA 01/2022 - 02/2011
5	AnticoagulantsIBA 03/2020 - 06/2002
5	Troponin IIBA 01/2018 - 09/2008
5	Creatine Kinase (Creatine Phosphokinase)IBA 07/2009 - 01/2002
5	sibrafibanIBA 08/2007 - 08/2003
5	Platelet Membrane GlycoproteinsIBA 02/2007 - 07/2002
4	Growth Differentiation Factor 15IBA 01/2024 - 01/2017
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 03/2011
4	Peptide Hydrolases (Proteases)FDA Link 12/2018 - 03/2014
4	thienopyridineIBA 03/2017 - 02/2009

Therapy/Procedure

125	Therapeutics 01/2024 - 06/2002
91	Percutaneous Coronary Intervention 12/2023 - 06/2002
44	Stents 03/2022 - 08/2002
36	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 09/2004
22	Thrombolytic Therapy 01/2022 - 01/2000
10	Patient Readmission 03/2017 - 09/2002
7	Blood Transfusion (Blood Transfusions) 01/2018 - 12/2007
5	Secondary Prevention 12/2018 - 08/2003
4	Conservative Treatment 01/2023 - 01/2021